Patent · US Active

Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna

US9243247B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2012
Grant dateJan 26, 2016
Priority date—
Expiry dateMay 24, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/141
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a use of an miRNA of an Epstein-Barr virus (EBV), more specifically, EBV miR-BART4-5p, miR-BART4-3p, miR-BART1-5p, miR-BART15-3p, miR-BART5-5p, miR-BART5-3p, miR-BART16-5p, miR-BART16-3p, miR-BART17-3p, miR-BART21-3p, miR-BART18-5p, miR-BART7-5p, miR-BART9-5p, miR-BART22-5p, miR-BART20-3p, miR-BART13-5p, miR-BART13-3p, miR-BART2-3p, and mimics thereof for promoting apoptosis or inhibiting cell growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.